- Lorlatinib Induced Severe Refractory Hyperlipidemia: A Cardio-Oncology Challenge in ALK Positive NSCLC
-
Board no. 1067Mo1067
S. Sarangi{1}, K. Coombes{2}, R. Saravanabavanandan{3}, A. R. Palvia{1}, S. Murphy{4}, S. Singireddy{5}, K. Kalvakuri{6};Generic 'disconnected' Message
{1}Internal Medicine, Peoria, IL, {2}Internal Medicine, University of Illinois College of Medicine/OSF St Francis, Peoria, IL, {3}Internal Medicine, University of Illinois COM, Peoria, Peoria, IL, {4}Internal Medicine, University of Illinois College of Medicine- Peoria, Peoria, IL, {5}Cardiology, OSF, Peoria, IL, {6}Cardiology, University of Illinois College of Medicine/OSF St Francis, Peoria, IL.CommunitiesNavigationSession TypeOnsite Viewing
Enter Note
Go to previous page in this tab
Session
